Novo NordiskSee all their emails

Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial

A real announcement email from Novo Nordisk. Captured September 21, 2026.

Make this email yours

Migma AI designs one like it with your logo, colors, and images.

Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial email from Novo Nordisk screenshot

Captured Announcement

Novo Nordisk announces topline results from phase 3 REIMAGINE 5 and REDEFINE 9 trials for CagriSema.

Single column layout featuring a top company logo, followed by extensive press release text, bullet points, structured data tables detailing trial results, investor contacts, and a legal footer.

Original email and brand assets belong to their respective owners. Design notes describe the creative, not campaign results.